Subscribe To
Apls deadline alert: rosen, a leading law firm, encourages apellis pharmaceuticals, inc. investors with losses in excess of $100k to secure counsel before important october 2 deadline in securities cl
NEW YORK, Sept. 30, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Apellis ...
September 30, 2023, 8:46 pm
Apls deadline alert: rosen, a leading law firm, encourages apellis pharmaceuticals, inc. investors with losses in excess of $100k to secure counsel before important october 2 deadline in securities cl
NEW YORK, Sept. 30, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Apellis ...
September 30, 2023, 8:46 pm
Apls deadline alert: rosen, a leading law firm, encourages apellis pharmaceuticals, inc. investors with losses in excess of $100k to secure counsel before important october 2 deadline in securities cl
NEW YORK, Sept. 30, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Apellis ...
September 30, 2023, 8:46 pm
Apls deadline alert: rosen, a leading law firm, encourages apellis pharmaceuticals, inc. investors with losses in excess of $100k to secure counsel before important october 2 deadline in securities cl
NEW YORK, Sept. 30, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Apellis ...
September 30, 2023, 8:46 pm
Apls deadline alert: rosen, a leading law firm, encourages apellis pharmaceuticals, inc. investors with losses in excess of $100k to secure counsel before important october 2 deadline in securities cl
NEW YORK, Sept. 30, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Apellis ...
September 30, 2023, 8:46 pm
Apls deadline alert: rosen, a leading law firm, encourages apellis pharmaceuticals, inc. investors with losses in excess of $100k to secure counsel before important october 2 deadline in securities cl
NEW YORK, Sept. 30, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Apellis ...
September 30, 2023, 8:46 pm
Is recursion pharmaceuticals stock a buy?
It has multiple programs in its pipeline, which focuses on rare diseases and cancer. Its use of artificial intelligence made the stock a hot buy earli...
September 30, 2023, 9:15 am
Thermo fisher: i'm waiting for a better valuation in this high-quality business
Thermo Fisher Scientific provides laboratory instruments, reagents, and consumables for scientific research and healthcare applications. These are the...
September 30, 2023, 4:02 am
Gsk: strong positioning and trading at historical discount
GSK is a leading biopharmaceutical company with a focus on vaccines and products for major diseases. GS...
September 29, 2023, 2:27 pm
Sharps technology announces closing of $5.6 million registered direct and private placement
NEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) — Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical ...
September 29, 2023, 1:54 pm
Structure therapeutics stock soars on positive weight loss data
Structure Therapeutics Inc shares surged 34% to $50.34 in midday trading on Friday after the clinical-stage global bio...
September 29, 2023, 12:55 pm
Outlook therapeutics® requests type a meeting with fda
ISELIN, N.J., Sept. 29, 2023 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutic...
September 29, 2023, 12:05 pm
Are medical stocks lagging align technology (algn) this year?
Here is how Align Technology (ALGN) and Aurinia pharmaceuticals (AUPH) have performed compared to their...
September 29, 2023, 11:17 am
Avalyn to provide keynote presentation at the formulation & delivery u.s. 2023 conference
SEATTLE, Sept. 29, 2023 (GLOBE NEWSWIRE) — Avalyn Pharma Inc., a clinical-stage biopharmaceutical com...
September 29, 2023, 10:30 am
Why is tonix pharmaceuticals (tnxp) stock down 29% today?
Tonix pharmaceuticals (NASDAQ: TNXP ) stock is falling hard on Friday after the clinical-stage bio
September 29, 2023, 9:17 am
Dyadic to present at industry and investor events in october
JUPITER, Fla., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnolo...
September 29, 2023, 8:30 am
Theseus pharmaceuticals: picking up the pieces after a lead failure
Theseus pharmaceuticals experienced significant losses after discontinuing its lead program, leaving it...
September 29, 2023, 7:35 am
Poolbeg pharma closes chapter on patent challenge
Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF), the clinical-stage biopharmaceutical group, has announced t...
September 29, 2023, 2:47 am
Rosen, trusted national trial counsel, encourages infinity pharmaceuticals, inc. investors with losses in excess of $100k to secure counsel before important deadline in securities class action – infi
NEW YORK, Sept. 28, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Infinity
September 28, 2023, 9:00 pm
Regeneron to report third quarter 2023 financial and operating results and host conference call and webcast on november 2, 2023
TARRYTOWN, N.Y., Sept. 28, 2023 (GLOBE NEWSWIRE) — Regeneron pharmaceuticals, Inc. (NASDAQ: REGN) tod...
September 28, 2023, 8:05 pm